BioPharmCatalyst
LightNews LightNews
biopharmcatalyst.bsky.social
BioPharmCatalyst
@biopharmcatalyst.bsky.social
360 followers 160 following 620 posts
FDA catalyst calendar, newsletters, and more. We do not provide investment advice or recommendations. #biotech #stocks

https://www.biopharmcatalyst.com/
Posts Replies Media Videos
biopharmcatalyst.bsky.social
$CALC ends Phase 2 KOURAGE trial in AKI due to safety concerns. No drug-related deaths. Will review data, continue pancreatitis trial, and advance second CRAC inhibitor.

www.biopharmcatalyst.com/news/2026/ca...
Pre-Market Updates 01/28/26
export-download.canva.com
January 28, 2026 at 1:40 PM
biopharmcatalyst.bsky.social
$NTLA FDA lifts clinical hold on MAGNITUDE-2 Phase 3 trial for ATTRv-PN. More biotech tickers: $PHGE $CRDF $NUWE $ABOS $USBC $PMN $CING $MBAI $DRMA

www.biopharmcatalyst.com/news/2026/bi...
Daily Updates 01/27/26
export-download.canva.com
January 27, 2026 at 9:30 PM
biopharmcatalyst.bsky.social
$CRDF: Interim Phase 2 shows onvansertib combo boosts efficacy in 1L RAS-mut mCRC vs. SoC. Outperforms FOLFOX combo. #PremarketMovers

www.biopharmcatalyst.com/news/2026/ca...
Pre-Market Updates 01/27/26
export-download.canva.com
January 27, 2026 at 1:40 PM
biopharmcatalyst.bsky.social
$MBAI regains Nasdaq compliance, moving closer to merger with MBody AI. #BiotechUpdates

www.biopharmcatalyst.com/news/2026/ch...
Daily Updates 01/26/26
export-download.canva.com
January 26, 2026 at 9:30 PM
biopharmcatalyst.bsky.social
$MRK ends $RVMD acquisition talks over valuation disagreement (~$30B). $RVMD, $SXTP, $REVB, $SRPT among pre-market movers.

www.biopharmcatalyst.com/news/2026/re...
Pre-Market Updates 01/26/26
export-download.canva.com
January 26, 2026 at 1:40 PM
biopharmcatalyst.bsky.social
$SXTP partners with Runway Health to make ARAKODA malaria prevention more accessible via travel-focused telehealth for at-risk travelers.

www.biopharmcatalyst.com/news/2026/ad...
Daily Updates 01/23/26
export-download.canva.com
January 23, 2026 at 9:30 PM
biopharmcatalyst.bsky.social
BioPharmCatalyst Weekly Watchlist: Key biotech catalysts & tickers (NTLA, RLYB, MNOV, more). Get daily biotech investing insights. Full list: [link] www.biopharmcatalyst.com/news/2026/bi...
January 23, 2026 at 9:15 PM
biopharmcatalyst.bsky.social
MOVE’s merger partner Corvex secured a long-term Nvidia H200 GPU lease. Their all-stock merger, announced in November, gives Corvex shareholders majority ownership.

www.biopharmcatalyst.com/news/2026/gr...
Pre-Market Updates 01/23/26
export-download.canva.com
January 23, 2026 at 1:40 PM
biopharmcatalyst.bsky.social
$SXTP teams with Runway Health to make FDA-approved ARAKODA malaria prevention more accessible for travelers via telehealth. #biotech

www.biopharmcatalyst.com/news/2026/60...
Daily Updates 01/22/26
export-download.canva.com
January 22, 2026 at 9:30 PM
biopharmcatalyst.bsky.social
$GLSI up premarket as FDA okays first commercial GP2 lot for Phase 3 breast cancer trial. Other movers: $SXTP $CORT $IOBT $GRI $AYTU $CABA $CUE $TBPH $PBM.

www.biopharmcatalyst.com/news/2026/gr...
Pre-Market Updates 01/22/26
export-download.canva.com
January 22, 2026 at 1:40 PM
biopharmcatalyst.bsky.social
$LSTA to be acquired by Kuva Labs for up to $53M, $4.00/share cash—an 85% premium. More biotech news: $PBM $ZURA $IOBT $NVAX $VERO $ADTX $CUE $AKAN $LEGN

www.biopharmcatalyst.com/news/2026/ps...
Daily Updates 01/21/26
export-download.canva.com
January 21, 2026 at 9:30 PM
biopharmcatalyst.bsky.social
$VERO to delist from Nasdaq, citing compliance costs; last trading day set for Feb 6, 2026. $LSTA $VERO $IOBT $HOTH $APLS $AYTU $ADTX $PAVM $SHPH $KMTS

www.biopharmcatalyst.com/news/2026/li...
Pre-Market Updates 01/21/26
export-download.canva.com
January 21, 2026 at 1:40 PM
biopharmcatalyst.bsky.social
$CRVS soquelitinib Phase 1 in atopic dermatitis: 75% EASI 75, 25% EASI 90, 33% IGA 0/1 at 8 weeks. #biotech

www.biopharmcatalyst.com/news/2026/co...
Daily Updates 01/20/26
export-download.canva.com
January 20, 2026 at 9:30 PM
biopharmcatalyst.bsky.social
Pre-market movers: $RAPT, $CRVS, $JAGX, $BTTC, $IBRX, $RMTI, $SHPH, $AEON, $VERO, $PRFX.

www.biopharmcatalyst.com/news/2026/ra...
Pre-Market Updates 01/20/26
export-download.canva.com
January 20, 2026 at 1:40 PM
biopharmcatalyst.bsky.social
Madryn Asset Management ups $VERO stake to 91%, urges cost cuts, possible delisting/deregistration (13D/A). More biotech news 👇

www.biopharmcatalyst.com/news/2026/ja...
Daily Updates 01/19/26
export-download.canva.com
January 19, 2026 at 9:30 PM
biopharmcatalyst.bsky.social
$VERO, $JAGX, $VVOS, $IBRX, $PRFX, $TLSA, $ATPC, $GTBP, $MTVA, $GELS among top pre-market movers.

LINK
Pre-Market Updates 01/19/26
export-download.canva.com
January 19, 2026 at 1:40 PM
biopharmcatalyst.bsky.social
Madryn Asset Mgmt now holds 91% of $VERO, pushing for cost cuts, delisting & deregistration per 13D/A filing. More biotech updates 👇

www.biopharmcatalyst.com/news/2026/ja...
Daily Updates 01/16/26
export-download.canva.com
January 16, 2026 at 9:30 PM
biopharmcatalyst.bsky.social
BioPharmCatalyst Watchlist: Top biotech stocks with key FDA catalysts this week. Daily updates, news & movers. #biotech #stockwatchlist www.biopharmcatalyst.com/news/2026/bi...
January 16, 2026 at 9:15 PM
biopharmcatalyst.bsky.social
Madryn ups $VERO stake to 91%, eyes cost cuts, possible delisting. Privatization or restructuring likely. Shareholders may face reduced liquidity. More corporate actions expected.

www.biopharmcatalyst.com/news/2026/ve...
Pre-Market Updates 01/16/26
export-download.canva.com
January 16, 2026 at 1:40 PM
biopharmcatalyst.bsky.social
$MTVA prices $8.1M offering at $3.10/unit with warrants; up to $24M more if exercised. Funds clinical work and operations. #biotech

www.biopharmcatalyst.com/news/2026/me...
Daily Updates 01/15/26
export-download.canva.com
January 15, 2026 at 9:30 PM
biopharmcatalyst.bsky.social
$PSTV announces $15M offering: 39.5M units at $0.38/unit, each with a five-year warrant, funding CNS cancer drug programs. 30-day over-allotment option included.

www.biopharmcatalyst.com/news/2026/pl...
Daily Updates 01/14/26
export-download.canva.com
January 14, 2026 at 9:30 PM
biopharmcatalyst.bsky.social
$BCTX announces $30M public offering: 5.37M units at $5.59/unit, each with a share & 5-yr $6.93 warrant. Warrants trade as "BCTXL" on Nasdaq Jan 14, 2026. Proceeds fund operations.

www.biopharmcatalyst.com/news/2026/br...
Pre-Market Updates 01/14/26
export-download.canva.com
January 14, 2026 at 1:40 PM
biopharmcatalyst.bsky.social
$XTLB acquires 85% of NeuroNOS from $XAIR, entering autism market with Nobel-led team and two FDA orphan drug designations. High-impact move in a field lacking therapies.

www.biopharmcatalyst.com/news/2026/xt...
Daily Updates 01/13/26
export-download.canva.com
January 13, 2026 at 9:30 PM
biopharmcatalyst.bsky.social
$SPRC to acquire Xylo’s MUSE system IP for up to 19.99% equity; aims for global commercialization after Xylo’s $3M China success.

www.biopharmcatalyst.com/news/2026/sc...
Pre-Market Updates 01/13/26
export-download.canva.com
January 13, 2026 at 1:40 PM
biopharmcatalyst.bsky.social
$ATRA got an FDA CRL for EBVALLO; ALLELE trial now deemed insufficient for approval in EBV+ PTLD. More biotech news: $LYRA $BIOA $DAWN $BDSX $FHTX $CLRB $FBRX $WINT $SHPH

www.biopharmcatalyst.com/news/2026/at...
Daily Updates 01/12/26
export-download.canva.com
January 12, 2026 at 9:30 PM